Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.53 - $0.93 $153,787 - $269,853
-290,165 Reduced 89.66%
33,473 $19,000
Q4 2023

Feb 15, 2024

BUY
$0.63 - $1.14 $1,575 - $2,849
2,500 Added 0.78%
323,638 $268,000
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $3,709 - $6,226
-3,312 Reduced 1.02%
321,138 $362,000
Q2 2023

Aug 14, 2023

BUY
$1.31 - $2.04 $253,770 - $395,184
193,718 Added 148.18%
324,450 $519,000
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $30,370 - $61,787
20,945 Added 19.08%
130,732 $198,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $10,122 - $16,285
5,011 Added 4.78%
109,787 $263,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $36,089 - $57,816
-18,413 Reduced 14.95%
104,776 $215,000
Q2 2022

Aug 22, 2022

BUY
$1.3 - $2.64 $22,480 - $45,653
17,293 Added 16.33%
123,189 $239,000
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $6,725 - $9,931
2,862 Added 2.78%
105,896 $260,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $16,819 - $33,062
5,760 Added 5.92%
103,034 $331,000
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $175,938 - $234,231
35,329 Added 57.03%
97,274 $511,000
Q2 2021

Aug 12, 2021

BUY
$2.56 - $5.49 $20,712 - $44,419
8,091 Added 15.02%
61,945 $340,000
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $2,969 - $5,796
1,104 Added 2.09%
53,854 $147,000
Q3 2020

Nov 13, 2020

SELL
$2.98 - $5.2 $13,880 - $24,221
-4,658 Reduced 8.11%
52,750 $211,000
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $11,463 - $21,225
5,006 Added 9.55%
57,408 $226,000
Q1 2020

May 14, 2020

SELL
$1.92 - $4.39 $7,645 - $17,480
-3,982 Reduced 7.06%
52,402 $129,000
Q4 2019

Feb 13, 2020

BUY
$2.41 - $4.4 $83,087 - $151,694
34,476 Added 157.37%
56,384 $230,000
Q3 2019

Nov 13, 2019

BUY
$2.17 - $3.14 $1,390 - $2,012
641 Added 3.01%
21,908 $56,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $7,068 - $8,493
2,794 Added 15.12%
21,267 $63,000
Q1 2019

May 15, 2019

SELL
$2.51 - $3.73 $8,034 - $11,939
-3,201 Reduced 14.77%
18,473 $55,000
Q4 2018

Feb 15, 2019

BUY
$1.59 - $2.66 $11,133 - $18,625
7,002 Added 47.72%
21,674 $52,000
Q3 2018

Nov 20, 2018

BUY
$1.59 - $2.42 $6,360 - $9,680
4,000 Added 37.48%
14,672 $31,000
Q2 2018

Aug 10, 2018

SELL
$2.26 - $4.65 $5,335 - $10,978
-2,361 Reduced 18.12%
10,672 $24,000
Q1 2018

May 17, 2018

SELL
$3.51 - $6.04 $23,794 - $40,945
-6,779 Reduced 34.22%
13,033 $61,000
Q4 2017

Feb 13, 2018

BUY
$3.26 - $4.78 $64,587 - $94,701
19,812
19,812 $65,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.